Microchip Technology Inc (MCHP) stock
MCHPNasdaqSemiconductors & Related DevicesFiscal year ends March 31Also trades as MCHPP
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 12/30134% above fair value
$77.34−3.78 (-4.66%)
Close on Oct 30, 2026Market cap $42.00BP/E 115.4Yield 2.35%
Earnings
Microchip Technology's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
Nov 5, 2026
Q2 FY2027 · estimated, after the close
Revenue, Q1 FY2027
$1.49B
+38.1% on a year earlier
Non-GAAP diluted net income per common share, Q1 FY2027
$0.76
$0.27 a year earlier
Latest guidance
Reaffirmed
Aug 6, 2026 · 10 items
Quarterly results
Revenue and earnings per share from each of Microchip Technology's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q2 FY2027ended Sep 30, 2026 | Nov 5, 2026Expected | – | – | – | – | – |
| Q1 FY2027ended Jun 30, 2026 | Aug 6, 2026after the close | $1.49B | +38.1% | $0.37 | $0.76 | Release |
| Q4 FY2026ended Mar 31, 2026 | May 7, 2026after the close | $1.31B | +35.1% | $0.21 | $0.57 | Release |
| Q3 FY2026ended Dec 31, 2025 | Jan 5, 2026after the close | – | – | – | – | Release |
| Q2 FY2026ended Sep 30, 2025 | Nov 6, 2025after the close | $1.14B | -2.1% | $0.03 | $0.35 | Release |
| Q1 FY2026ended Jun 30, 2025 | Aug 7, 2025after the close | $1.08B | -13.3% | -$0.09 | $0.27 | Release |
| Q4 FY2025ended Mar 31, 2025 | May 8, 2025after the close | $970.50M | -26.8% | -$0.29 | $0.11 | Release |
| Q3 FY2025ended Dec 31, 2024 | Feb 6, 2025after the close | $1.03B | -41.9% | -$0.10 | $0.20 | Release |
| Q2 FY2025ended Sep 30, 2024 | Nov 5, 2024after the close | $1.16B | -48.4% | $0.14 | $0.46 | Release |
| Q1 FY2025ended Jun 30, 2024 | Aug 1, 2024after the close | $1.24B | -45.8% | $0.24 | $0.53 | Release |
| Q4 FY2024ended Mar 31, 2024 | May 6, 2024after the close | $1.33B | -40.6% | $0.28 | $0.57 | Release |
| Q3 FY2024ended Dec 31, 2023 | Feb 1, 2024after the close | $1.77B | -18.6% | $0.77 | $1.08 | Release |
| Q2 FY2024ended Sep 30, 2023 | Nov 2, 2023after the close | $2.25B | +8.7% | $1.21 | $1.62 | Release |
| Q1 FY2024ended Jun 30, 2023 | Aug 3, 2023after the close | $2.29B | +16.5% | $1.21 | $1.64 | Release |
| Q4 FY2023ended Mar 31, 2023 | May 4, 2023after the close | $2.23B | +21.1% | $1.09 | $1.64 | Release |
| Q3 FY2023ended Dec 31, 2022 | Feb 2, 2023after the close | $2.17B | +23.4% | $1.04 | $1.56 | Release |
| Q2 FY2023ended Sep 30, 2022 | Nov 3, 2022after the close | $2.07B | +25.6% | $0.98 | $1.46 | Release |
| Q1 FY2023ended Jun 30, 2022 | Aug 2, 2022after the close | $1.96B | – | $0.90 | $1.37 | Release |
| Q4 FY2022ended Mar 31, 2022 | May 9, 2022after the close | $1.84B | – | $0.77 | $1.35 | Release |
| Q3 FY2022ended Dec 31, 2021 | Feb 3, 2022after the close | $1.76B | – | $0.62 | $1.20 | Release |
| Q2 FY2022ended Sep 30, 2021 | Nov 4, 2021after the close | $1.65B | – | $0.43 | $1.07 | Release |
| Q1 FY2022ended Jun 30, 2021 | Aug 3, 2021after the close | – | – | – | – | Release |
| Q4 FY2021ended Mar 31, 2021 | May 6, 2021after the close | – | – | – | – | Release |
| Q3 FY2021ended Dec 31, 2020 | Feb 4, 2021during market hours | – | – | – | – | Release |
| Q2 FY2021ended Sep 30, 2020 | Nov 5, 2020after the close | – | – | – | – | Release |
| Q1 FY2021ended Jun 30, 2020 | Aug 4, 2020after the close | – | – | – | – | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Microchip Technology's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| net sales | Q2 FY2027 | +7% – +9% | – | New | Aug 6, 2026 |
| Net Sales | Q2 FY2027 | $1.59B – $1.62B | – | New | Aug 6, 2026 |
| Gross ProfitGAAP | Q2 FY2027 | 65.4% – 66.3% | – | New | Aug 6, 2026 |
| Gross Profitnon-GAAP | Q2 FY2027 | 66% – 67% | – | New | Aug 6, 2026 |
| Operating IncomeGAAP | Q2 FY2027 | 28.1% – 28.9% | – | New | Aug 6, 2026 |
| Operating Incomenon-GAAP | Q2 FY2027 | 38.5% – 39.5% | – | New | Aug 6, 2026 |
| Diluted net income per common shareGAAP | Q2 FY2027 | $0.53 – $0.54 | – | New | Aug 6, 2026 |
| Diluted net income per common sharenon-GAAP | Q2 FY2027 | $0.91 – $0.95 | – | New | Aug 6, 2026 |
| Capital expenditures | Q2 FY2027 | $20.00M – $25.00M | – | New | Aug 6, 2026 |
| Capital expenditures | FY2027 | $100.00M | $100.00M | Reaffirmed | Aug 6, 2026 |
Guidance vs results
The last range Microchip Technology gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| Q1 FY2027 | EPS (GAAP) | $0.28 – $0.29 | $0.37 | Above range |
| Q1 FY2027 | non-GAAP earnings per share | $0.67 – $0.71 | $0.76 | Above range |
| Q1 FY2027 | Revenue | $1.44B – $1.47B | $1.49B | Above range |
| Q2 FY2026 | Diluted net (loss) per common share | $0.30 – $0.36 | $0.35 | Within range |
| Q2 FY2026 | EPS (GAAP) | -$0.04 – -$0.01 | $0.03 | Above range |
| Q2 FY2026 | Revenue | $1.11B – $1.15B | $1.14B | Within range |
| Q1 FY2026 | EPS (GAAP) | -$0.15 – -$0.07 | -$0.09 | Within range |
| Q1 FY2026 | Revenue | $1.02B – $1.07B | $1.08B | Above range |
| Q4 FY2025 | Earnings (loss) per Diluted Share | $0.05 – $0.15 | $0.11 | Within range |
| Q4 FY2025 | EPS (GAAP) | -$0.24 – -$0.14 | -$0.29 | Below range |
| Q3 FY2025 | Earnings (Loss) per Diluted Share | $0.25 – $0.35 | $0.20 | Below range |
| Q3 FY2025 | EPS (GAAP) | -$0.04 – $0.03 | -$0.10 | Below range |
| Q3 FY2025 | Revenue | $1.03B – $1.10B | $1.03B | Within range |
| Q2 FY2025 | Earnings per Diluted Share | $0.40 – $0.46 | $0.46 | Within range |
| Q2 FY2025 | EPS (GAAP) | $0.10 – $0.14 | $0.14 | Within range |
| Q2 FY2025 | Revenue | $1.12B – $1.18B | $1.16B | Within range |
| Q1 FY2025 | Earnings per Diluted Share | $0.48 – $0.56 | $0.53 | Within range |
| Q1 FY2025 | EPS (GAAP) | $0.19 – $0.24 | $0.24 | Within range |
| Q1 FY2025 | Revenue | $1.22B – $1.26B | $1.24B | Within range |
| Q4 FY2024 | Earnings per Diluted Share | $0.46 – $0.68 | $0.57 | Within range |
| Q4 FY2024 | EPS (GAAP) | $0.13 – $0.32 | $0.28 | Within range |
| Q4 FY2024 | Revenue | $1.23B – $1.43B | $1.33B | Within range |
| Q3 FY2024 | Earnings per Diluted Share | $1.09 – $1.17 | $1.08 | Below range |
| Q3 FY2024 | EPS (GAAP) | $0.68 – $0.76 | $0.77 | Above range |
| Q3 FY2024 | Revenue | $1.80B – $1.92B | $1.77B | Below range |
| Q2 FY2024 | Earnings per Diluted Share | $1.60 – $1.64 | $1.62 | Within range |
| Q2 FY2024 | EPS (GAAP) | $1.18 – $1.21 | $1.21 | Within range |
| Q2 FY2024 | Revenue | $2.22B – $2.31B | $2.25B | Within range |
| Q1 FY2024 | Earnings per Diluted Share | $1.63 – $1.65 | $1.64 | Within range |
| Q1 FY2024 | EPS (GAAP) | $1.15 – $1.16 | $1.21 | Above range |
| Q1 FY2024 | Revenue | $2.26B – $2.32B | $2.29B | Within range |
| Q4 FY2023 | Earnings per Diluted Share | $1.61 – $1.63 | $1.64 | Above range |
| Q4 FY2023 | EPS (GAAP) | $1.07 – $1.09 | $1.09 | Within range |
| Q4 FY2023 | Revenue | $2.19B – $2.26B | $2.23B | Within range |
| Q3 FY2023 | Earnings per Diluted Share | $1.54 – $1.56 | $1.56 | Within range |
| Q3 FY2023 | EPS (GAAP) | $1.03 – $1.07 | $1.04 | Within range |
| Q3 FY2023 | Revenue | $2.14B – $2.18B | $2.17B | Within range |
| Q2 FY2023 | Earnings per Diluted Share | $1.42 – $1.46 | $1.46 | Within range |
| Q2 FY2023 | EPS (GAAP) | $0.94 – $0.95 | $0.98 | Above range |
| Q2 FY2023 | Revenue | $2.02B – $2.10B | $2.07B | Within range |
| Q1 FY2023 | Earnings per Diluted Share | $1.32 – $1.36 | $1.37 | Above range |
| Q1 FY2023 | EPS (GAAP) | $0.85 – $0.86 | $0.90 | Above range |
| Q1 FY2023 | Revenue | $1.92B – $1.99B | $1.96B | Within range |
| Q4 FY2022 | Earnings per Diluted Share | $1.22 – $1.28 | $1.35 | Above range |
| Q4 FY2022 | EPS (GAAP) | $0.66 – $0.68 | $0.77 | Above range |
| Q4 FY2022 | Revenue | $1.79B – $1.85B | $1.84B | Within range |
| Q3 FY2022 | Earnings per Diluted Share | $1.14 – $1.20 | $1.20 | Within range |
| Q3 FY2022 | EPS (GAAP) | $0.58 – $0.60 | $0.62 | Above range |
| Q3 FY2022 | Revenue | $1.72B – $1.78B | $1.76B | Within range |
Guidance history
Every forecast Microchip Technology put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Aug 6, 2026 | Capital expenditures | FY2027 | $100.00M | Reaffirmed |
| Aug 6, 2026 | Capital expenditures | Q2 FY2027 | $20.00M – $25.00M | New |
| Aug 6, 2026 | Diluted net income per common share | Q2 FY2027 | $0.91 – $0.95 | New |
| Aug 6, 2026 | Diluted net income per common share | Q2 FY2027 | $0.53 – $0.54 | New |
| Aug 6, 2026 | Gross Profit | Q2 FY2027 | 65.4% – 66.3% | New |
| Aug 6, 2026 | Gross Profit | Q2 FY2027 | 66% – 67% | New |
| Aug 6, 2026 | Operating Income | Q2 FY2027 | 28.1% – 28.9% | New |
| Aug 6, 2026 | Operating Income | Q2 FY2027 | 38.5% – 39.5% | New |
| Aug 6, 2026 | net sales | Q2 FY2027 | +7% – +9% | New |
| Aug 6, 2026 | Net Sales | Q2 FY2027 | $1.59B – $1.62B | New |
| May 7, 2026 | Capital expenditures | FY2027 | $100.00M | New |
| May 7, 2026 | Capital expenditures | Q1 FY2027 | $20.00M | New |
| May 7, 2026 | non-GAAP earnings per share | Q1 FY2027 | $0.67 – $0.71 | New |
| May 7, 2026 | Diluted net income per common share | Q1 FY2027 | $0.28 – $0.29 | New |
| May 7, 2026 | Gross Profit | Q1 FY2027 | 61.4% – 62.4% | New |
| May 7, 2026 | non‑GAAP gross margin | Q1 FY2027 | 62.25% – 63.25% | New |
| May 7, 2026 | Operating Income | Q1 FY2027 | 20.8% – 22.2% | New |
| May 7, 2026 | non-GAAP operating profit | Q1 FY2027 | 33% – 34.5% | New |
| May 7, 2026 | Diluted Common Shares Outstanding | Q1 FY2027 | 549.7 – 550.4 | New |
| May 7, 2026 | Diluted Common Shares Outstanding | Q1 FY2027 | 572.4 – 573.4 | New |
| May 7, 2026 | Operating Expenses | Q1 FY2027 | 40.2% – 40.6% | New |
| May 7, 2026 | non‑GAAP operating expense | Q1 FY2027 | 28.75% – 29.25% | New |
| May 7, 2026 | Other Expense, net | Q1 FY2027 | $49.20M – $49.80M | New |
| May 7, 2026 | Income Tax Provision | Q1 FY2027 | $67.60M – $89.90M | Raised |
| May 7, 2026 | Net income | Q1 FY2027 | $182.80M – $186.80M | Raised |
| May 7, 2026 | Net income attributable to common stockholders | Q1 FY2027 | $155.00M – $159.00M | Lowered |
| May 7, 2026 | Other Expense, net | Q1 FY2027 | $49.00M – $50.00M | New |
| May 7, 2026 | Income Tax Provision | Q1 FY2027 | $42.60M – $45.80M | Lowered |
| May 7, 2026 | Net income | Q1 FY2027 | $383.40M – $411.90M | Raised |
| May 7, 2026 | Net income attributable to common stockholders | Q1 FY2027 | $383.40M – $411.90M | Reaffirmed |
| May 7, 2026 | Net Sales | Q1 FY2027 | $1.44B – $1.47B | New |
| Jan 5, 2026 | net sales | Q3 FY2026 | $1.19B | Raised |
| Nov 6, 2025 | Capital expenditures | Q3 FY2026 | $15.00M – $25.00M | New |
| Nov 6, 2025 | Capital expenditures | FY2026 | $100.00M | Reaffirmed |
| Nov 6, 2025 | Diluted net (loss) income per common share | Q3 FY2026 | -$0.02 – $0.02 | New |
| Nov 6, 2025 | Gross Profit | Q3 FY2026 | 56.2% – 58.1% | New |
| Nov 6, 2025 | Operating Income | Q3 FY2026 | 7.7% – 10.3% | New |
| Nov 6, 2025 | Net Sales | Q3 FY2026 | $1.11B – $1.15B | New |
| Aug 7, 2025 | Capital expenditures | Q2 FY2026 | $35.00M – $40.00M | New |
| Aug 7, 2025 | Capital expenditures | FY2026 | $100.00M | Reaffirmed |
| Aug 7, 2025 | Diluted net (loss) per common share | Q2 FY2026 | $0.30 – $0.36 | New |
| Aug 7, 2025 | Diluted net (loss) per common share | Q2 FY2026 | -$0.04 – -$0.01 | New |
| Aug 7, 2025 | Gross Profit | Q2 FY2026 | 54.3% – 56.2% | New |
| Aug 7, 2025 | Gross Profit | Q2 FY2026 | 55% – 57% | New |
| Aug 7, 2025 | Operating Income | Q2 FY2026 | 6.3% – 8.8% | New |
| Aug 7, 2025 | Operating Income | Q2 FY2026 | 22.2% – 24.6% | New |
| Aug 7, 2025 | Operating Expenses | Q2 FY2026 | 32.4% – 32.8% | New |
| Aug 7, 2025 | Diluted Common Shares Outstanding | Q2 FY2026 | 539.8 | New |
| Aug 7, 2025 | Diluted Common Shares Outstanding | Q2 FY2026 | 568.3 – 569.3 | New |
| Aug 7, 2025 | Operating Expenses | Q2 FY2026 | 47.4% – 48% | New |
| Aug 7, 2025 | Other Expense, net | Q2 FY2026 | $54.70M – $55.30M | New |
| Aug 7, 2025 | Income Tax Provision | Q2 FY2026 | $10.20M – $23.40M | Lowered |
| Aug 7, 2025 | Net income | Q2 FY2026 | $4.40M – $23.40M | Lowered |
| Aug 7, 2025 | Dividends on Series A Preferred Stock | Q2 FY2026 | -$27.80M | Lowered |
| Aug 7, 2025 | Net (loss) income attributable to common stockholders | Q2 FY2026 | -$23.50M – -$4.50M | Raised |
| Aug 7, 2025 | Other Expense, net | Q2 FY2026 | $54.50M – $55.50M | New |
| Aug 7, 2025 | Income Tax Provision | Q2 FY2026 | $18.10M – $21.70M | Lowered |
| Aug 7, 2025 | Net income | Q2 FY2026 | $172.80M – $206.70M | Raised |
| Aug 7, 2025 | Net (loss) income attributable to common stockholders | Q2 FY2026 | $172.80M – $206.70M | Reaffirmed |
| Aug 7, 2025 | Net Sales | Q2 FY2026 | $1.11B – $1.15B | New |
| May 8, 2025 | Capital expenditures | FY2026 | $100.00M | New |
| May 8, 2025 | Capital expenditures | Q1 FY2026 | $20.00M – $25.00M | New |
| May 8, 2025 | Diluted net (loss) per common share | Q1 FY2026 | -$0.15 – -$0.07 | New |
| May 8, 2025 | Gross Profit | Q1 FY2026 | 51.2% – 53.2% | New |
| May 8, 2025 | Operating Income | Q1 FY2026 | 0.2% – 3.9% | New |
| May 8, 2025 | Net Sales | Q1 FY2026 | $1.02B – $1.07B | New |
| Feb 6, 2025 | Capital expenditures | FY2025 | $135.00M | Lowered |
| Feb 6, 2025 | Capital expenditures | Q4 FY2025 | $23.00M | New |
| Feb 6, 2025 | Earnings (loss) per Diluted Share | Q4 FY2025 | $0.05 – $0.15 | New |
| Feb 6, 2025 | Earnings (loss) per Diluted Share | Q4 FY2025 | -$0.24 – -$0.14 | New |
| Feb 6, 2025 | Gross Profit | Q4 FY2025 | 51.2% – 53.1% | New |
| Feb 6, 2025 | Gross Profit | Q4 FY2025 | 52% – 54% | New |
| Feb 6, 2025 | Operating Income (loss) | Q4 FY2025 | -8.9% – -2.9% | New |
| Feb 6, 2025 | Operating Income (loss) | Q4 FY2025 | 11.5% – 16.3% | New |
| Feb 6, 2025 | Operating Expenses | Q4 FY2025 | 37.7% – 40.5% | New |
| Feb 6, 2025 | Other Expense, net | Q4 FY2025 | $69.70M – $71.30M | New |
| Feb 6, 2025 | Income Tax (Benefit) Provision | Q4 FY2025 | -$24.50M – -$19.80M | Lowered |
| Feb 6, 2025 | Net Income (loss) | Q4 FY2025 | -$128.50M – -$79.40M | Lowered |
| Feb 6, 2025 | Other Expense, net | Q4 FY2025 | $69.50M – $71.50M | New |
| Feb 6, 2025 | Income Tax (Benefit) Provision | Q4 FY2025 | $5.00M – $13.60M | Lowered |
| Feb 6, 2025 | Net Income (loss) | Q4 FY2025 | $29.30M – $79.90M | Raised |
| Feb 6, 2025 | Operating Expenses | Q4 FY2025 | 56.1% – 60% | New |
| Nov 5, 2024 | Capital expenditures | FY2025 | $150.00M | New |
| Nov 5, 2024 | Capital expenditures | Q3 FY2025 | $20.00M | New |
| Nov 5, 2024 | Earnings (Loss) per Diluted Share | Q3 FY2025 | $0.25 – $0.35 | New |
| Nov 5, 2024 | Earnings (Loss) per Diluted Share | Q3 FY2025 | -$0.04 – $0.03 | New |
| Nov 5, 2024 | Gross Profit | Q3 FY2025 | 56.2% – 58.1% | New |
| Nov 5, 2024 | Gross Profit | Q3 FY2025 | 57% – 59% | New |
| Nov 5, 2024 | Operating Income | Q3 FY2025 | 4.8% – 9.1% | New |
| Nov 5, 2024 | Operating Income | Q3 FY2025 | 22.2% – 25.8% | New |
| Nov 5, 2024 | Net Sales | Q3 FY2025 | $1.03B – $1.10B | New |
| Aug 1, 2024 | Capital expenditures | Q2 FY2025 | $35.00M – $40.00M | New |
| Aug 1, 2024 | Capital expenditures | FY2025 | $175.00M | Reaffirmed |
| Aug 1, 2024 | Earnings per Diluted Share | Q2 FY2025 | $0.40 – $0.46 | New |
| Aug 1, 2024 | Earnings per Diluted Share | Q2 FY2025 | $0.10 – $0.14 | New |
| Aug 1, 2024 | Gross Profit | Q2 FY2025 | 57.8% – 58.7% | New |
| Aug 1, 2024 | Gross Profit | Q2 FY2025 | 58.5% – 59.5% | New |
| Aug 1, 2024 | Operating Income | Q2 FY2025 | 11.2% – 13.6% | New |
| Aug 1, 2024 | Operating Income | Q2 FY2025 | 27.5% – 29.5% | New |
| Aug 1, 2024 | Diluted Common Shares Outstanding | Q2 FY2025 | 542 – 542.6 | New |
| Aug 1, 2024 | Diluted Common Shares Outstanding | Q2 FY2025 | 542 – 542.6 | New |
| Aug 1, 2024 | Operating Expenses | Q2 FY2025 | 45.1% – 46.6% | New |
| Aug 1, 2024 | Operating Expenses | Q2 FY2025 | 30% – 31% | New |
| Aug 1, 2024 | Other Expense, net | Q2 FY2025 | $57.80M – $58.20M | New |
| Aug 1, 2024 | Income Tax Provision | Q2 FY2025 | $13.60M – $23.60M | Lowered |
| Aug 1, 2024 | Net Income | Q2 FY2025 | $54.30M – $79.00M | Raised |
| Aug 1, 2024 | Other Expense, net | Q2 FY2025 | $58.00M | New |
| Aug 1, 2024 | Income Tax Provision | Q2 FY2025 | $32.50M – $37.70M | Lowered |
| Aug 1, 2024 | Net Income | Q2 FY2025 | $217.50M – $252.40M | Raised |
| Aug 1, 2024 | Net Sales | Q2 FY2025 | $1.12B – $1.18B | New |
| May 6, 2024 | Capital expenditures | Q1 FY2025 | $60.00M – $70.00M | New |
| May 6, 2024 | Capital expenditures | FY2025 | $175.00M | New |
| May 6, 2024 | Earnings per Diluted Share | Q1 FY2025 | $0.48 – $0.56 | New |
| May 6, 2024 | Earnings per Diluted Share | Q1 FY2025 | $0.19 – $0.24 | New |
| May 6, 2024 | Gross Profit | Q1 FY2025 | 58.5% – 60.5% | New |
| May 6, 2024 | Gross Profit | Q1 FY2025 | 59% – 61% | New |
| May 6, 2024 | Operating Income | Q1 FY2025 | 15.9% – 18.4% | New |
| May 6, 2024 | Operating Income | Q1 FY2025 | 30.25% – 32.75% | New |
| May 6, 2024 | Net Sales | Q1 FY2025 | $1.22B – $1.26B | New |
| Feb 1, 2024 | Capital expenditures | Q4 FY2024 | $50.00M – $60.00M | New |
| Feb 1, 2024 | Capital expenditures | FY2024 | $300.00M – $310.00M | Lowered |
| Feb 1, 2024 | Earnings per Diluted Share | Q4 FY2024 | $0.46 – $0.68 | New |
| Feb 1, 2024 | Earnings per Diluted Share | Q4 FY2024 | $0.13 – $0.32 | New |
| Feb 1, 2024 | Gross Profit | Q4 FY2024 | 58.5% – 61.1% | New |
| Feb 1, 2024 | Gross Profit | Q4 FY2024 | 59% – 61.6% | New |
| Feb 1, 2024 | Operating Income | Q4 FY2024 | 11.6% – 20% | New |
| Feb 1, 2024 | Operating Income | Q4 FY2024 | 28.3% – 34.7% | New |
| Feb 1, 2024 | Diluted Common Shares Outstanding | Q4 FY2024 | 545.5 – 546.5 | New |
| Feb 1, 2024 | Diluted Common Shares Outstanding | Q4 FY2024 | 545.5 – 546.5 | New |
| Feb 1, 2024 | Operating Expenses | Q4 FY2024 | 41.1% – 46.9% | New |
| Feb 1, 2024 | Operating Expenses | Q4 FY2024 | 26.9% – 30.7% | New |
| Feb 1, 2024 | Other Expense, net | Q4 FY2024 | $55.30M – $57.70M | New |
| Feb 1, 2024 | Income Tax Provision | Q4 FY2024 | $17.40M – $52.30M | Lowered |
| Feb 1, 2024 | Net Income | Q4 FY2024 | $69.40M – $174.90M | Raised |
| Feb 1, 2024 | Other Expense, net | Q4 FY2024 | $55.50M – $57.50M | New |
| Feb 1, 2024 | Income Tax Provision | Q4 FY2024 | $40.80M – $61.20M | Lowered |
| Feb 1, 2024 | Net Income | Q4 FY2024 | $250.40M – $375.80M | Raised |
| Feb 1, 2024 | Net Sales | Q4 FY2024 | $1.23B – $1.43B | New |
| Nov 2, 2023 | Capital expenditures | Q3 FY2024 | $50.00M – $70.00M | New |
| Nov 2, 2023 | Capital expenditures | FY2024 | $300.00M – $325.00M | Lowered |
| Nov 2, 2023 | Earnings per Diluted Share | Q3 FY2024 | $1.09 – $1.17 | New |
| Nov 2, 2023 | Earnings per Diluted Share | Q3 FY2024 | $0.68 – $0.76 | New |
| Nov 2, 2023 | Gross Profit | Q3 FY2024 | 63.6% – 64.6% | New |
| Nov 2, 2023 | Gross Profit | Q3 FY2024 | 64% – 65% | New |
| Nov 2, 2023 | Operating Income | Q3 FY2024 | 29.4% – 31.4% | New |
| Nov 2, 2023 | Operating Income | Q3 FY2024 | 40.7% – 42.3% | New |
| Nov 2, 2023 | Diluted Common Shares Outstanding | Q3 FY2024 | 546 – 547 | New |
| Nov 2, 2023 | Diluted Common Shares Outstanding | Q3 FY2024 | 546 – 547 | New |
| Nov 2, 2023 | Operating Expenses | Q3 FY2024 | 33.2% – 34.2% | New |
| Nov 2, 2023 | Operating Expenses | Q3 FY2024 | 22.7% – 23.3% | New |
| Nov 2, 2023 | Other Expense, net | Q3 FY2024 | $50.80M – $53.20M | New |
| Nov 2, 2023 | Income Tax Provision | Q3 FY2024 | $107.80M – $134.30M | Raised |
| Nov 2, 2023 | Net Income | Q3 FY2024 | $371.30M – $413.90M | Raised |
| Nov 2, 2023 | Other Expense, net | Q3 FY2024 | $51.00M – $53.00M | New |
| Nov 2, 2023 | Income Tax Provision | Q3 FY2024 | $90.20M – $115.10M | Raised |
| Nov 2, 2023 | Net Income | Q3 FY2024 | $592.80M – $642.40M | Raised |
| Nov 2, 2023 | Net Sales | Q3 FY2024 | $1.80B – $1.92B | New |
| Aug 3, 2023 | Capital expenditures | Q2 FY2024 | $90.00M – $100.00M | New |
| Aug 3, 2023 | Capital expenditures | FY2024 | $300.00M – $400.00M | Reaffirmed |
| Aug 3, 2023 | Earnings per Diluted Share | Q2 FY2024 | $1.60 – $1.64 | New |
| Aug 3, 2023 | Earnings per Diluted Share | Q2 FY2024 | $1.18 – $1.21 | New |
| Aug 3, 2023 | Gross Profit | Q2 FY2024 | 68% – 68.2% | New |
| Aug 3, 2023 | Gross Profit | Q2 FY2024 | 68.3% – 68.5% | New |
| Aug 3, 2023 | Operating Income | Q2 FY2024 | 38.6% – 39.3% | New |
| Aug 3, 2023 | Operating Income | Q2 FY2024 | 47.8% – 48.4% | New |
| Aug 3, 2023 | Net Sales | Q2 FY2024 | $2.22B – $2.31B | New |
| May 4, 2023 | Capital expenditures | Q1 FY2024 | $100.00M – $120.00M | New |
| May 4, 2023 | Capital expenditures | FY2024 | $300.00M – $400.00M | New |
| May 4, 2023 | Earnings per Diluted Share | Q1 FY2024 | $1.63 – $1.65 | New |
| May 4, 2023 | Earnings per Diluted Share | Q1 FY2024 | $1.15 – $1.16 | New |
| May 4, 2023 | Gross Margin | Q1 FY2024 | 68% – 68.2% | New |
| May 4, 2023 | Gross Margin | Q1 FY2024 | 68.3% – 68.5% | New |
| May 4, 2023 | Operating Income | Q1 FY2024 | 38.7% – 39.4% | New |
| May 4, 2023 | Operating Income | Q1 FY2024 | 47.8% – 48.4% | New |
| May 4, 2023 | Net Sales | Q1 FY2024 | $2.26B – $2.32B | New |
| Feb 2, 2023 | Capital expenditures | Q4 FY2023 | $154.00M – $174.00M | New |
| Feb 2, 2023 | Capital expenditures | FY2023 | $525.00M – $545.00M | Narrowed |
| Feb 2, 2023 | Earnings per Diluted Share | Q4 FY2023 | $1.61 – $1.63 | New |
| Feb 2, 2023 | Earnings per Diluted Share | Q4 FY2023 | $1.07 – $1.09 | New |
| Feb 2, 2023 | Gross Margin | Q4 FY2023 | 67.8% – 68% | New |
| Feb 2, 2023 | Gross Margin | Q4 FY2023 | 68.1% – 68.3% | New |
| Feb 2, 2023 | Operating Income | Q4 FY2023 | 37.2% – 37.6% | New |
| Feb 2, 2023 | Operating Income | Q4 FY2023 | 47.3% – 47.7% | New |
| Feb 2, 2023 | inventory days | Q4 FY2023 | 157 – 164 | New |
| Feb 2, 2023 | Diluted Common Shares Outstanding | Q4 FY2023 | 554 – 554.4 | New |
| Feb 2, 2023 | Diluted Common Shares Outstanding | Q4 FY2023 | 554 – 554.4 | New |
| Feb 2, 2023 | Operating Expenses | Q4 FY2023 | 30.3% – 30.7% | New |
| Feb 2, 2023 | Operating Expenses | Q4 FY2023 | 20.6% – 20.8% | New |
| Feb 2, 2023 | Other Expense, net | Q4 FY2023 | $45.80M – $48.20M | New |
| Feb 2, 2023 | Income Tax Provision | Q4 FY2023 | $165.10M – $204.10M | Raised |
| Feb 2, 2023 | Net Income | Q4 FY2023 | $596.40M – $603.00M | Raised |
| Feb 2, 2023 | Other Expense, net | Q4 FY2023 | $46.00M – $48.00M | New |
| Feb 2, 2023 | Income Tax Provision | Q4 FY2023 | $99.00M – $123.40M | Raised |
| Feb 2, 2023 | Net Income | Q4 FY2023 | $891.30M – $904.70M | Raised |
| Feb 2, 2023 | Net Sales | Q4 FY2023 | $2.19B – $2.26B | New |
| Nov 3, 2022 | Capital expenditures | Q3 FY2023 | $105.00M – $125.00M | New |
| Nov 3, 2022 | Capital expenditures | FY2023 | $500.00M – $550.00M | Reaffirmed |
| Nov 3, 2022 | Earnings per Diluted Share | Q3 FY2023 | $1.54 – $1.56 | New |
| Nov 3, 2022 | Earnings per Diluted Share | Q3 FY2023 | $1.03 – $1.07 | New |
| Nov 3, 2022 | Gross Margin | Q3 FY2023 | 67.5% – 67.7% | New |
| Nov 3, 2022 | Gross Margin | Q3 FY2023 | 67.8% – 68% | New |
| Nov 3, 2022 | Operating Income | Q3 FY2023 | 36.6% – 36.9% | New |
| Nov 3, 2022 | Operating Income | Q3 FY2023 | 46.9% – 47.3% | New |
| Nov 3, 2022 | Diluted Common Shares Outstanding | Q3 FY2023 | 556.4 – 556.9 | New |
| Nov 3, 2022 | Diluted Common Shares Outstanding | Q3 FY2023 | 556.4 – 556.9 | New |
| Nov 3, 2022 | inventory days | Q3 FY2023 | 143 – 147 | New |
| Nov 3, 2022 | Operating Expenses | Q3 FY2023 | 30.7% – 30.9% | New |
| Nov 3, 2022 | Operating Expenses | Q3 FY2023 | 20.7% – 20.9% | New |
| Nov 3, 2022 | Other Expense, net | Q3 FY2023 | $52.90M – $55.30M | New |
| Nov 3, 2022 | Income Tax Provision | Q3 FY2023 | $134.70M – $176.00M | Raised |
| Nov 3, 2022 | Net Income | Q3 FY2023 | $572.80M – $593.30M | Raised |
| Nov 3, 2022 | Other Expense, net | Q3 FY2023 | $53.00M – $55.00M | New |
| Nov 3, 2022 | Income Tax Provision | Q3 FY2023 | $93.00M – $106.20M | Raised |
| Nov 3, 2022 | Net Income | Q3 FY2023 | $855.60M – $868.40M | Raised |
| Nov 3, 2022 | Net Sales | Q3 FY2023 | $2.14B – $2.18B | New |
| Aug 2, 2022 | Capital expenditures | Q2 FY2023 | $130.00M – $150.00M | New |
| Aug 2, 2022 | Capital expenditures | FY2023 | $500.00M – $550.00M | Raised |
| Aug 2, 2022 | Earnings per Diluted Share | Q2 FY2023 | $1.42 – $1.46 | New |
| Aug 2, 2022 | Earnings per Diluted Share | Q2 FY2023 | $0.94 – $0.95 | New |
| Aug 2, 2022 | Gross Margin | Q2 FY2023 | 66.9% – 67.3% | New |
| Aug 2, 2022 | Gross Margin | Q2 FY2023 | 67.3% – 67.7% | New |
| Aug 2, 2022 | Operating Income | Q2 FY2023 | 45.6% – 46.4% | New |
| Aug 2, 2022 | Operating Income | Q2 FY2023 | 34.7% – 35.7% | New |
| Aug 2, 2022 | Diluted Common Shares Outstanding | Q2 FY2023 | 560.1 – 560.7 | New |
| Aug 2, 2022 | inventory days | Q2 FY2023 | 127 – 132 | New |
| Aug 2, 2022 | Operating Expenses | Q2 FY2023 | 21.3% – 21.7% | New |
| Aug 2, 2022 | Other Expense, net | Q2 FY2023 | $53.40M – $55.80M | New |
| Aug 2, 2022 | Income Tax Provision | Q2 FY2023 | $119.90M – $163.00M | Raised |
| Aug 2, 2022 | Net Income | Q2 FY2023 | $528.40M – $530.60M | Raised |
| Aug 2, 2022 | Other Expense, net | Q2 FY2023 | $53.50M – $55.50M | New |
| Aug 2, 2022 | Income Tax Provision | Q2 FY2023 | $73.80M – $96.50M | Raised |
| Aug 2, 2022 | Net Income | Q2 FY2023 | $794.90M – $822.90M | Raised |
| Aug 2, 2022 | Operating Expenses | Q2 FY2023 | 31.6% – 32.2% | New |
| Aug 2, 2022 | Diluted Common Shares Outstanding | Q2 FY2023 | 560.1 – 560.7 | New |
| Aug 2, 2022 | Net Sales | Q2 FY2023 | $2.02B – $2.10B | New |
| May 9, 2022 | Capital expenditures | Q1 FY2023 | $120.00M – $140.00M | New |
| May 9, 2022 | Capital expenditures | FY2023 | $450.00M – $550.00M | New |
| May 9, 2022 | Earnings per Diluted Share | Q1 FY2023 | $1.32 – $1.36 | New |
| May 9, 2022 | Earnings per Diluted Share | Q1 FY2023 | $0.85 – $0.86 | New |
| May 9, 2022 | Gross Margin | Q1 FY2023 | 66.4% – 66.8% | New |
| May 9, 2022 | Gross Margin | Q1 FY2023 | 66.8% – 67.2% | New |
| May 9, 2022 | Operating Income | Q1 FY2023 | 33.2% – 34.2% | New |
| May 9, 2022 | Operating Income | Q1 FY2023 | 44.8% – 45.6% | New |
| May 9, 2022 | Diluted Common Shares Outstanding | Q1 FY2023 | 562.8 – 563.8 | New |
| May 9, 2022 | inventory days | Q1 FY2023 | 128 – 134 | Lowered |
| May 9, 2022 | Operating Expenses | Q1 FY2023 | 32.6% – 33.2% | New |
| May 9, 2022 | Operating Expenses | Q1 FY2023 | 21.6% – 22% | New |
| May 9, 2022 | Other Expense, net | Q1 FY2023 | $49.80M – $52.20M | New |
| May 9, 2022 | Income Tax Provision | Q1 FY2023 | $108.70M – $147.90M | Raised |
| May 9, 2022 | Net Income | Q1 FY2023 | $479.10M – $481.50M | Raised |
| May 9, 2022 | Other Expense, net | Q1 FY2023 | $50.00M – $52.00M | New |
| May 9, 2022 | Income Tax Provision | Q1 FY2023 | $68.80M – $89.90M | Raised |
| May 9, 2022 | Net Income | Q1 FY2023 | $740.50M – $766.30M | Raised |
| May 9, 2022 | Net Sales | Q1 FY2023 | $1.92B – $1.99B | New |
| Feb 3, 2022 | Capital expenditures | Q4 FY2022 | $135.00M – $145.00M | New |
| Feb 3, 2022 | Capital expenditures | FY2022 | $390.00M – $400.00M | Raised |
| Feb 3, 2022 | Earnings per Diluted Share | Q4 FY2022 | $1.22 – $1.28 | New |
| Feb 3, 2022 | Earnings per Diluted Share | Q4 FY2022 | $0.66 – $0.68 | New |
| Feb 3, 2022 | Gross Margin | Q4 FY2022 | 65.8% – 66.1% | New |
| Feb 3, 2022 | Gross Margin | Q4 FY2022 | 66.2% – 66.6% | New |
| Feb 3, 2022 | Operating Income | Q4 FY2022 | 28.6% – 29.5% | New |
| Feb 3, 2022 | Operating Income | Q4 FY2022 | 44% – 44.8% | New |
| Feb 3, 2022 | Net Sales | Q4 FY2022 | $1.79B – $1.85B | New |
| Nov 4, 2021 | Capital expenditures | Q3 FY2022 | $70.00M – $90.00M | New |
| Nov 4, 2021 | Capital expenditures | FY2022 | $350.00M – $400.00M | New |
| Nov 4, 2021 | Earnings per Diluted Share | Q3 FY2022 | $1.14 – $1.20 | New |
| Nov 4, 2021 | Earnings per Diluted Share | Q3 FY2022 | $0.58 – $0.60 | New |
| Nov 4, 2021 | Gross Margin | Q3 FY2022 | 65.3% – 65.7% | New |
| Nov 4, 2021 | Gross Margin | Q3 FY2022 | 65.8% – 66.2% | New |
| Nov 4, 2021 | Operating Income | Q3 FY2022 | 26.7% – 27.9% | New |
| Nov 4, 2021 | Operating Income | Q3 FY2022 | 43.1% – 43.9% | New |
| Nov 4, 2021 | Net Sales | Q3 FY2022 | $1.72B – $1.78B | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Microchip Technology filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Microchip Technology Announces Proposed Private Offering of $600 Million of Convertible Senior NotesNews
- News
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- News
- News
- Results